What is GHK-Cu?
GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide complex that binds copper with high affinity. First identified in human plasma in 1973 by Dr. Loren Pickart, GHK-Cu has since been found in saliva, urine, and various tissues. Its concentration in human plasma decreases significantly with age—from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60—a decline that prompted researchers to investigate why.
| Full Name | Glycyl-L-Histidyl-L-Lysine:Copper(II) |
| Type | Tripeptide-Copper Complex |
| Amino Acids | 3 (Glycine-Histidine-Lysine) |
| Molecular Weight | ~403.9 Da (with Cu²⁺) |
| Copper Binding | High affinity (log K = 16.44) |
| Discovery | 1973, isolated from human plasma |
| Natural Occurrence | Plasma, saliva, urine |
Discovery and scientific history
The discovery of GHK-Cu emerged from aging research. Dr. Pickart observed that liver cells from older donors, when exposed to young plasma, showed renewed biosynthetic activity. The active factor was eventually isolated and identified as the GHK tripeptide. The subsequent finding that GHK forms a strong complex with copper(II) ions opened new avenues of investigation into copper-mediated biological processes.
Over the following decades, research expanded from its initial liver cell observations into diverse areas including dermatology, wound healing, and gene expression studies. The peptide’s ability to deliver copper ions to tissues in a biologically active form has proven to be a key aspect of its research interest.
Research areas
Skin biology and remodeling
GHK-Cu has been extensively studied in the context of skin biology. Research suggests it may stimulate collagen synthesis (types I, III, and V), promote elastin production, and support glycosaminoglycan synthesis (including decorin and dermatan sulfate). Studies in cell culture models indicate it may enhance fibroblast proliferation and activity, processes central to skin structure and remodeling.
Wound healing research
Multiple preclinical and some limited clinical studies have examined GHK-Cu’s role in wound healing. Research suggests it may promote angiogenesis, attract immune cells to wound sites, and provide antioxidant protection. The copper component is believed to serve as a cofactor for enzymes involved in tissue repair, including lysyl oxidase (important for collagen cross-linking) and superoxide dismutase (an antioxidant enzyme).
Anti-inflammatory properties
Studies indicate GHK-Cu may modulate inflammatory responses. Research has shown potential suppression of certain pro-inflammatory cytokines while promoting anti-inflammatory mediators. This dual action is of particular interest in chronic inflammatory conditions studied in animal models.
Hair follicle research
Some researchers have investigated GHK-Cu’s effects on hair follicle biology. Studies suggest it may enlarge hair follicle size and stimulate hair growth in certain models. This area of research is relatively newer and continues to develop.
Gene expression studies
Some of the most interesting recent research involves GHK-Cu’s effects on gene expression. Broad genome-wide studies suggest it may modulate the expression of numerous genes—some studies have identified effects on over 4,000 genes. This includes upregulation of genes associated with tissue repair and downregulation of genes associated with tissue degradation.
Mechanism of action
GHK-Cu’s mechanism is complex and involves several interconnected pathways:
- Copper ion delivery: GHK transports copper ions with high efficiency. The histidine residue coordinates the copper ion, and the complex can deliver Cu²⁺ to cells and enzymes that require it as a cofactor.
- Enzyme activation: Copper is essential for numerous enzymes, including lysyl oxidase (collagen cross-linking), tyrosinase (melanin production), cytochrome c oxidase (cellular energy), and superoxide dismutase (antioxidant defense).
- Growth factor modulation: Research suggests GHK-Cu may influence the expression and activity of several growth factors, including TGF-β, VEGF, and FGF.
- ECM remodeling: By simultaneously promoting collagen synthesis and regulating metalloproteinase activity, GHK-Cu may support balanced extracellular matrix turnover.
- Antioxidant function: The copper complex demonstrates superoxide dismutase-like activity, potentially protecting tissues from oxidative damage.
Comparison with other copper peptides
GHK-Cu is the most widely studied copper peptide, but it is not the only one. Other copper-binding peptides include AHK-Cu (alanyl-histidyl-lysine) and various synthetic variants. What distinguishes GHK-Cu is its natural occurrence in human tissues, its exceptionally high copper binding affinity, and the breadth of research supporting its biological activities. Researchers selecting a copper peptide for study should consider the specific binding characteristics and published literature for each variant.
Research handling notes
GHK-Cu storage protocol
Lyophilized form: Store at -20°C, protected from light and moisture. The copper complex adds stability compared to some other peptides, but standard cold storage protocols should still be followed.
Reconstituted: Use bacteriostatic water. The solution should appear a very faint blue color due to the copper ion. Store at 2-8°C and use within 2-4 weeks.
Note: GHK-Cu solutions are sensitive to pH. Maintain neutral to slightly acidic conditions (pH 5.5-7.0) for optimal stability.
Research use disclaimer
GHK-Cu is sold strictly for in vitro and in vivo research purposes only. It is not intended for human consumption or therapeutic use. Information presented here summarizes published preclinical research and does not constitute medical advice. Researchers should comply with all applicable regulations.
GHK-Cu in research: frequently asked questions
- What distinguishes GHK-Cu from simple copper salt supplementation in research?
- GHK-Cu is a specific peptide-copper complex with precise coordination geometry that mediates targeted cellular responses including collagen synthesis stimulation, anti-inflammatory signaling, and gene expression modulation. These effects are not replicated by inorganic copper salts (gluconate, chloride) which simply provide ionic copper without the peptide-directed delivery mechanism.
- What is the mechanism of GHK-Cu’s gene expression modulation?
- Genome-wide studies have shown GHK-Cu influences the expression of hundreds to thousands of genes. The proposed mechanism involves copper delivery to nuclear enzymes and transcription factor cofactors, influencing histone modification and chromatin remodeling. Pickart et al. (2014) documented broad genomic effects in multiple cell line studies, suggesting systemic tissue-level modulation rather than single-pathway effects.
- What purity should researchers look for in GHK-Cu?
- Research-grade GHK-Cu should be ≥98% pure by HPLC analysis with mass spectrometry identity confirmation matching the GHK-Cu molecular weight (~340 Da for the copper complex). The solution characteristic faint blue color from the Cu²⁺ ion is a visual quality indicator but not a substitute for analytical testing. Batch-specific COAs should document all parameters.
- How does GHK-Cu stability compare to other research peptides?
- GHK-Cu is relatively stable due to the copper coordination that protects the peptide backbone. Lyophilized GHK-Cu maintains stability for 24+ months at -20°C. Reconstituted solutions should be stored at 2-8°C at pH 5.5-7.0 and used within 4 weeks. The copper-histidine coordinate bond provides stability advantages over free peptides at similar sizes.
- What cell types are used in GHK-Cu dermatology research?
- Primary human dermal fibroblasts (HDF) and keratinocytes are the most commonly used cell types. Studies have also used 3D skin organoid models, reconstructed human epidermis (RHE), and hair follicle dermal papilla cells. The choice depends on whether researchers are investigating dermal remodeling (fibroblasts), epidermal effects (keratinocytes), or hair biology (papilla cells).
Recent research highlights
Research interest in GHK-Cu has accelerated significantly, with a reported 1,016% increase in research queries year-over-year as of 2026. Key recent developments include:
- Microbiome interactions: Emerging research on GHK-Cu’s effects on skin microbiome composition and barrier function, building on Guthrie et al.’s earlier work on peptide-microbiome interactions
- Neurological applications: Expanding research into GHK-Cu’s neuroprotective potential, particularly in oxidative stress models relevant to neurodegenerative disease research
- Wound healing biomaterials: Integration of GHK-Cu into hydrogel, nanoparticle, and scaffold delivery systems for controlled release in wound healing research models
- Hair follicle research: Refined protocols for ex vivo hair follicle organ culture with GHK-Cu showing dose-dependent effects on anagen phase duration
Barrientos S et al. (2008) provided foundational evidence for growth factor and cytokine interactions in wound healing that frames much of the current GHK-Cu investigation. PMID: 18695656. Wollina U and Abdel-Naser MB (2004) reviewed the broader copper peptide clinical research landscape, providing useful historical context. PMID: 15186353.
CertaPeptides GHK-Cu research supply
CertaPeptides provides GHK-Cu in 50mg and 100mg research vials manufactured to ≥99% HPLC purity standards. Each batch includes a Certificate of Analysis documenting HPLC purity percentage, mass spectrometry identity confirmation (target MW ~340 Da), endotoxin levels, and visual inspection results. All products are shipped cold-packaged from Romania with EU-wide delivery and are intended strictly for laboratory research use only.
Related: Peptides for Healing and Recovery Research
References
- Pickart L, Vasquez-Soltero JM, Margolina A. (2015). GHK Peptide as a Natural Modulator of Multiple cellular Pathways in Skin Regeneration. BioMed Research International, 2015, 648108. PMID: 26236730.
- Pickart L, Thaler MM. (1973). Tripeptide in human serum which prolongs survival of normal liver cells. Nature New Biology, 243(124), 85-87. PMID: 4512559.
- Maquart FX, et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 238(2), 343-346. PMID: 3169264.
- Freedman JH, et al. (1982). Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution. Biochemistry, 21(19), 4540-4544. PMID: 7138802.
- Pickart L, Vasquez-Soltero JM, Margolina A. (2014). GHK and DNA: resetting the human genome to health. BioMed Research International, 2014, 151479. PMID: 24971312.
- Pickart L. (2008). The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition, 19(8), 969-988. PMID: 18644225.